article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

MBC supports optimal clinical practice, demonstrates the value of integrated care teams, and improves outcomes. Conclusion CFHA believes that MBC is a critical process that guides, informs, and enhances clinical practices at all levels of integrated care systems. Journal of Evaluation in Clinical Practice, 18(1), 104–110.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. FDA gives no rationale for interpreting the apparently broad statutory term “medical information” in such a restrictive manner.

Clinic 52
article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

Ashwin Kotwal: Yeah, and Thomas, I know this is something we’ve talked about as a group too, which is how do you translate some of these scales that we use in large studies to our clinical practice? ” Eric: And I remember from my last podcast, Ashwin, it was about individualizing our approach to loneliness too, right?

IT 99
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Legalization is moving forward in several states , following the lead of Oregon and Colorado.

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. And I’m wondering from a practical standpoint, when you think about pain management in those with a history of substance use disorder who have substance use disorder active like is buprenorphine like your go to drug right now?

article thumbnail

Do statins reduce mortality in older people? Findings from a longitudinal study using primary care records

BMJ

A 20-year observational follow-up study of the clinical trial WOSCOPS (West of Scotland Coronary Prevention Study) made use of national mortality records and electronic health records to estimate the long-term survival effect of statins. Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification. Eur Heart J.